Antonio J. Plata
Malaga, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Mortality risk of ESBL producers in Escherichia coli bacteraemia: a comprehensive analysis using the PROBAC cohort.
Journal: The Journal of antimicrobial chemotherapy
Published: December 01, 2025
External validation of the predictive ability of Charson, SOFA, Pitt, INCREMENT-ESBL and bloodstream infection mortality Risk for 30-day-mortality in bacteraemia using the PROBAC cohort data.
Journal: Infectious diseases (London, England)
Published: July 09, 2025
Real-world evidence of dalbavancin effectiveness as consolidation therapy in infective endocarditis due to Enterococcus spp.
Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
Published: May 11, 2024
Differences in clinical outcomes of bloodstream infections caused by Klebsiella aerogenes, Klebsiella pneumoniae and Enterobacter cloacae: a multicentre cohort study.
Journal: Annals of clinical microbiology and antimicrobials
Published: March 03, 2024
Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial.
Journal: The Lancet. Infectious diseases
Published: August 23, 2023
Impact of Intermediate Susceptibility to Penicillin on Antimicrobial Treatment and Outcomes of Endocarditis Caused by Viridans and Gallolyticus Group Streptococci.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 22, 2023
Infective Endocarditis in Diabetic Patients: A Different Profile with Prognostic Consequences.
Journal: Journal of clinical medicine
Published: April 15, 2022
Clinical Factors Associated with Reinfection versus Relapse in Infective Endocarditis: Prospective Cohort Study.
Journal: Journal of clinical medicine
Published: January 17, 2021
Four weeks versus six weeks of ampicillin plus ceftriaxone in Enterococcus faecalis native valve endocarditis: A prospective cohort study.
Journal: PloS one
Published: February 29, 2020
DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci.
Journal: Annals of clinical microbiology and antimicrobials
Published: February 15, 2019
Dalbavancin in the treatment of different gram-positive infections: a real-life experience.
Journal: International journal of antimicrobial agents
Published: June 20, 2017
Last Updated: 09/26/2026